공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 CRO(Contract Research Outsourcing) 시장

Contract Research Outsourcing

리서치사 Global Industry Analysts, Inc.
발행일 2021년 01월 상품 코드 503813
페이지 정보 영문 314 Pages
가격
US $ 5,800 ₩ 6,602,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 17,400 ₩ 19,808,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 CRO(Contract Research Outsourcing) 시장 Contract Research Outsourcing
발행일 : 2021년 01월 페이지 정보 : 영문 314 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 CRO(Contract Research Outsourcing) 시장에 대해 조사했으며, 시장 개요와 2022년까지 예측, 지역별 동향 및 시장에 진출하는 주요 기업 개요 등의 정보를 전해드립니다.

제1장 서론, 조사 방법, 제품 정의

제2장 주요 요약

  • 업계 개요
    • CRO(Contract Research Outsourcing) 서비스 시장 성장을 촉진하는 연구 개발 프로젝트 아웃소싱
    • 성장 촉진요인
    • 거시적 동향이 촉진하는 CRO 수요
    • 투자 확대가 성장을 촉진
    • 임상시험의 주요 치료 분야
    • CRO 시장에 영향을 미치는 요인
    • CRO에 대한 의존이 증가하는 제약회사와 바이오테크놀러지 기업
    • 향후 전망
    • 지역별 발전
    • CRO의 향후 모델
  • 경쟁 시나리오
  • 성장 촉진요인, 시장 동향, 해결해야 할 과제
    • 사이트 선정과 피험자 모집
    • 효율화를 위한 제휴
    • 디지털 기술의 도입
    • 후기 서비스 수요와 예산 절감
    • 독물학 서비스
    • 규제 동향
    • 고령화가 CRO의 기회로
    • 의료 지출 증가가 제네릭 의약품 수요를 촉진
  • CRO(Contract Research Outsourcing) : 개요
    • 개념
    • 임상시험수탁기관(CRO : Contract Research Organizations)
    • 주요 CRO 서비스
    • CRO로부터 얻을 수 있는 이점
    • Drug Discovery
    • 전임상 연구
    • 임상 연구 등
  • 최근 업계 활동
  • 주요 기업
    • Albany Molecular Research, Inc.
    • Charles River Laboratories International, Inc.
    • Chiltern International Ltd.
    • ICON plc
    • INC Research, LLC
    • InVentiv Health, Inc.
    • Jubilant Biosys Ltd.
    • Laboratory Corporation of America® Holdings
    • PAREXEL International Corp.
    • Pharmaceutical Product Development, LLC.
    • Pharmaron
    • PRA Health Sciences, Inc.
    • Quintiles IMS Holdings, Inc.
    • Ricerca Biosciences LLC
    • Sygnature Discovery Limited
    • SynteractHCR
    • WuXi AppTec
  • 세계 시장 전망

제3장 시장

  • 미국
  • 캐나다
  • 일본
  • 유럽
  • 아시아태평양 지역
  • 기타 국가

경쟁 구도

KSM 17.06.07

Abstract:

CRO Market Slumps by -1.9% in 2020 Only to Emerge Stronger With Newer Dynamics in the Post COVID-19 World

The global market for Contract Research Outsourcing is expected to slump by -1.9% in the year 2020 and thereafter recover to reach US$72.1 billion by the year 2027, trailing a post COVID-19 CAGR of 7% over the analysis period 2020 through 2027. The COVID-19 crisis has thrown various challenges for the pharmaceutical & biopharmaceutical contract research outsourcing industry, while opening new avenues for growth across different domains. Contract research organizations serving pharmaceutical and vaccine companies were coerced to discontinue several studies owing to restrictions regarding movement of goods along with face-to-face interactions. These mandates affected central laboratories, clinical trial sites and timelines for completion of sponsored studies. Stringent guidelines enforced by countries prevented face-to-face meetings with clients, which delayed resolution of technical issues. The situation prompted various organizations to resort to video conferencing along with advanced technologies for addressing these issues. On the positive side, the COVID-19 pandemic drove the adoption of e-Clinical systems and offered new opportunities for pandemic-related research. The outbreak and associated changes in strategies required companies to bring their projects online and comply with high visibility and tight timelines. Various organizations implemented e-Clinical systems to avoid face-to-face interactions, enabling providers of these solutions to reap rich dividends. While the pandemic affected existing projects, it enabled the pharmaceutical & biopharmaceutical outsourcing industry to witness notable surge in R&D demand.

The trend prompted companies to shift their focus and fine-tune existing operations to ensure efficiency for COVID-19-related projects. In addition, the work-from-home trend and repurposing of projects enabled various players to pay more attention to strategic activities. The pandemic has brought various changes in the CRO industry by delaying clinical trials, requiring repurposing of development pipeline and prompting companies to explore new options to connect with patients. Factors like patient disinclination to travel and local restrictions made companies to delay or stop non-essential study visits. Organizations were affected by customer-related trial delays, access and limitations to specific trial sites, and disruptions in the supply chain. The shift towards COVID-19 vaccine and treatments increased the workload for CROs. Known for their high capacity and flexibility, majority of CROs effectively accommodated the volume within a short span. Contract research organizations made concerted efforts towards accommodation of new projects without compromising over existing projects for other medical conditions or indications. The pandemic is anticipated to benefit the biopharmaceutical drug development industry and strengthen drug development activity, requiring players to efficiently use digital solutions, data insights and patient engagements. Easing of restrictions and reopening of businesses are likely to bring non-COVID-19 trials on track and drive organizations to pay more attention to decentralized clinical trial solutions including digital platforms along with mobile phlebotomists and nurses. In addition, these clinical trials are expected to reduce the requirement for patients and other participants to travel, which remains a major challenge during the current scenario.

Changes in business operations for pharmaceutical companies are prompting CROs and other participants to adjust their practices. The impact of COVID-19 on face-to-face interactions with clients is driving various companies to implement new platforms for virtual connectivity. The technology is enabling organizations with global operations to efficiently serve their customers. In addition to limiting employee travel and considering remote working, organizations are adopting wearable cameras to assist clients in virtual audits and plant visits. These virtual meetings are providing an effective alternative to traditional personal contacts, on-site visits and face-to-face interactions. In addition, organizations are working closely with procurement teams for sourcing necessary supplies to ensure operational continuity and serve clients in a better way. The COVID-19 healthcare emergency has created a pressing need for a collaborative approach among health authorities, pharmaceutical players, regulators and CROs for developing and producing safe and effective treatments. The holistic approach combining resources and the required expertise is expected to pave way for efficient distribution of the impending vaccine globally. CROs are partnering with pharmaceutical companies for targeting data integrity and patient safety, as well as with other stakeholders including regulators and sites for patient safety-related considerations. Players are also implementing sophisticated solutions for research sites and clinical studies to reduce the burden on healthcare providers, patients and investigational sites. CROs are anticipated to play a critical role during the pandemic by taking responsibility for consistent on-site support.

Select Competitors (Total 152 Featured) -

  • Albany Molecular Research, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Clinical Biotech
  • ICON plc
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America® Holdings
  • Olon Ricerca Bioscience
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC.
  • Pharmaron
  • PRA Health Sciences, Inc.
  • Sygnature Discovery Limited
  • Syneos Health
  • SynteractHCR
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Delivers Mixed Results for Contract Research Outsourcing Industry
    • Players Focus on Collaborative Approach
    • Optimism Reigns in Latter Part of 2020
    • COVID-19 and Implications for Drug Development Regulations & Processes
    • Opportunities in COVID-19 Programs
    • Parallel Gains for Development & Manufacturing
    • Contract Research Outsourcing: An Introduction
    • Key Service Markets
    • Market Dynamics
    • Key Therapeutic Areas of Clinical Trial Research
    • EXHIBIT 1: Top 10 Therapeutic Categories by Number of R&D Products in 2020
    • Cost Savings Hold Relevance
    • Product Innovations & Enhanced Speed
    • Access to Expertise & Sophisticated Technology
    • Outlook
    • Regional Market Analysis
    • Future Model of CRO
    • COMPETITIVE SCENARIO
    • CRO: A Highly Fragmented Market
    • EXHIBIT 2: Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player
    • Partnership Models Pay Returns
    • Strategies and Tactical Programs
    • Large CROs Seek the Inorganic Growth Route
    • Key Opportunities for CROs
    • Technological Superiority: An Advantage
    • Consolidation to Gain Pace
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Uptrend in Advanced Medicine Concepts Favors Growth
    • Drug Developers Bet on CROs to Sail through Challenging Aspects
    • Pharmaceutical & Biopharmaceutical Firms Target Outsourcing
    • Gene Therapy Offers Exciting Opportunities for CROs
    • COVID-19 Creates a Pause in Gene Therapy Market Growth
    • Gene Therapy Set to Witness Rapid Growth Post COVID-19
    • EXHIBIT 3: Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026
    • Increasing Significance of Biologic Drugs Supports Market Demand
    • EXHIBIT 4: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
    • COVID-19 Drives Strong Gains for Biologics Activity
    • Opportunities Rife in Early Stage Drug Development
    • Notable Trends in Pharma/Biopharma R&D Impacting CROs
    • Advances in Digital/Technology and its Impact on Clinical Development
    • Significant Strides Taken in the Sphere of Current Clinical Research
    • Data Quality Oversight (DQO) Undergoes Change
    • Pharmacovigilance Set to Grow
    • Artificial Intelligence and Machine Learning Gain Interest
    • Orphan Drugs to the Fore
    • CROs Adapt New Technologies to See More Business in Future
    • Streamlining Development of Novel Trial Designs
    • Industry Witnesses Increased Spend on R&D Outsourcing
    • EXHIBIT 5: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
    • EXHIBIT 6: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019
    • Focus on Enhancing Site Selection and Patient Enrollment
    • CROs Enter into Alliances to Improve Efficiencies
    • Adoption of Digital Technologies Gains Pace
    • Toxicology Services Gain Notable Attention
    • Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
    • Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
    • EXHIBIT 7: Global Biopharma % R&D Outsourcing (2014-2022)
    • EXHIBIT 8: New FDA Drug Approvals (2010-2019): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
    • eClinical Solutions Gain Traction
    • Other Noteworthy Market Trends
    • Challenges Faced by Contract Research Organizations
    • Surging Global Population Offers Increased Growth Opportunities
    • EXHIBIT 9: World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050
    • Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
    • EXHIBIT 10: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 11: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 12: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • EXHIBIT 13: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • EXHIBIT 14: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Increasing Healthcare Expenditure and Demand for Generics to Drive Growth
    • EXHIBIT 15: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • EXHIBIT 16: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 2: World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 8: World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 11: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 14: World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 17: World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 23: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

    • GEOGRAPHIC MARKET ANALYSIS
    • UNITED STATES
    • Market Overview
    • COVID-19 Pandemic: Mixed Bag of Opportunities for CROs
    • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
    • Trial Services Witness Strong Demand
    • High Demand for Data Management Services
    • Risk-based Monitoring Catches Pace
    • Market Analytics
    • TABLE 25: USA Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 26: USA Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 27: USA 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 29: USA Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 30: USA 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • CANADA
    • TABLE 31: Canada Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 32: Canada Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 33: Canada 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 35: Canada Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 36: Canada 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 38: Japan Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 39: Japan 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 41: Japan Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 42: Japan 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • CHINA
    • Market Overview
    • Market Analytics
    • TABLE 43: China Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 44: China Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 45: China 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 47: China Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 48: China 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • EUROPE
    • Market Overview
    • Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments
    • Providers Expand Services in Downstream Drug Development
    • Market Analytics
    • TABLE 49: Europe Current & Future Analysis for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 50: Europe Historic Review for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 51: Europe 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 53: Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 54: Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 56: Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 57: Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • FRANCE
    • TABLE 58: France Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 59: France Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 60: France 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 62: France Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 63: France 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 65: Germany Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 66: Germany 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 68: Germany Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 69: Germany 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • ITALY
    • TABLE 70: Italy Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 71: Italy Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 72: Italy 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 74: Italy Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 75: Italy 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 77: UK Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 78: UK 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 80: UK Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 81: UK 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • SPAIN
    • TABLE 82: Spain Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 83: Spain Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 84: Spain 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 85: Spain Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 86: Spain Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 87: Spain 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • RUSSIA
    • TABLE 88: Russia Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 89: Russia Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 90: Russia 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 91: Russia Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 92: Russia Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 93: Russia 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • REST OF EUROPE
    • TABLE 94: Rest of Europe Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 95: Rest of Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 96: Rest of Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of Europe Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 98: Rest of Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 99: Rest of Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • ASIA-PACIFIC
    • Market Overview
    • Asia-Pacific to Push Up Volume Share in CRO Market
    • R&D Outsourcing in Life Sciences on Rise
    • Market Analytics
    • TABLE 100: Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 101: Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 102: Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for India and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 104: Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 105: Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 107: Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 108: Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • INDIA
    • Indian CROs Seek Opportunities
    • Market Analytics
    • TABLE 109: India Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 110: India Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 111: India 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 112: India Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 113: India Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 114: India 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • REST OF ASIA-PACIFIC
    • Market Overview
    • Australia: Popular Destination for Early Phase Clinical Trials
    • Market Analytics
    • TABLE 115: Rest of Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 116: Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 117: Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 118: Rest of Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 119: Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 120: Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • LATIN AMERICA
    • TABLE 121: Latin America Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 122: Latin America Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 123: Latin America 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 124: Latin America Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 125: Latin America Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 126: Latin America 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
    • REST OF WORLD
    • TABLE 127: Rest of World Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 128: Rest of World Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 129: Rest of World 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of World Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 131: Rest of World Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 132: Rest of World 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 210
Back to Top
전화 문의
F A Q